Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites.

implementation science long-acting injectable antiretroviral therapy

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 02 04 2022
accepted: 08 06 2022
entrez: 25 7 2022
pubmed: 26 7 2022
medline: 26 7 2022
Statut: epublish

Résumé

Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.

Identifiants

pubmed: 35873299
doi: 10.1093/ofid/ofac293
pii: ofac293
pmc: PMC9301580
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofac293

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH062246
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123396
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Références

AIDS Care. 2021 Jun;33(6):801-809
pubmed: 32408771
MMWR Morb Mortal Wkly Rep. 2019 Dec 06;68(48):1117-1123
pubmed: 31805031
AIDS Res Hum Retroviruses. 2021 Feb;37(2):75-88
pubmed: 33176429
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:23259582211009011
pubmed: 33902356
Stat Med. 2002 Aug 30;21(16):2409-19
pubmed: 12210625
J Acquir Immune Defic Syndr. 2007 Dec 1;46(4):395-401
pubmed: 18077831
Cult Health Sex. 2021 Aug;23(8):1066-1078
pubmed: 32436478
MMWR Morb Mortal Wkly Rep. 2018 Oct 19;67(41):1147-1150
pubmed: 30335734
J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):263-270
pubmed: 32530905
J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):190-197
pubmed: 30418298
Adm Policy Ment Health. 2011 Mar;38(2):65-76
pubmed: 20957426
AIDS Patient Care STDS. 2019 Mar;33(3):104-111
pubmed: 30844308
Nanomedicine (Lond). 2013 Nov;8(11):1807-13
pubmed: 23611617
PLoS One. 2018 Jan 5;13(1):e0190487
pubmed: 29304154
BMC Health Serv Res. 2021 Mar 20;21(1):255
pubmed: 33743684
AIDS Behav. 2017 Apr;21(4):1025-1033
pubmed: 27896552

Auteurs

Katerina A Christopoulos (KA)

Division of HIV, ID and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Jonathan Colasanti (J)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

Mallory O Johnson (MO)

Center for AIDS Prevention Studies, Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Manami Diaz Tsuzuki (M)

Division of HIV, ID and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Xavier A Erguera (XA)

Division of HIV, ID and Global Medicine, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Rey Flores (R)

Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois, USA.

Jared Kerman (J)

Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois, USA.

Kaylin Dance (K)

Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.

John A Sauceda (JA)

Center for AIDS Prevention Studies, Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Torsten B Neilands (TB)

Center for AIDS Prevention Studies, Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Samantha E Dilworth (SE)

Center for AIDS Prevention Studies, Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Kimberly A Koester (KA)

Center for AIDS Prevention Studies, Division of Prevention Science, Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Jose Gutierrez (J)

National Clinician Scholars Program, University of California San Francisco, San Francisco, California, USA.

John A Schneider (JA)

Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois, USA.

Elizabeth Montgomery (E)

Women's Global Health Imperative, RTI International, Berkeley, California, USA.

Moira C McNulty (MC)

Chicago Center for HIV Elimination, University of Chicago, Chicago, Illinois, USA.

Classifications MeSH